Herpes simplex virus (HSV)-specific proteins fall into at least three kinetic classes whose synthesis is sequentially and coordinately regulated. Temperaturesensitive (ts) mutants of one complementation group (1-2) are defective in the transition from immediate early to early and late protein synthesis. To elucidate the function of the 1-2 gene product in the HSV type 1 replicative cycle, nine ts mutants in this group were mapped by fine-structure analysis and characterized biochemically. Physical mapping by homotypic marker rescue has shown that all members of the group lie within the tenninally repeated sequences of the S region of the genome. Fine-structure genetic and physical mapping permitted the mutations to be ordered within these sequences. Because it has been shown that the message for VP175 and the DNA template specifying this protein extend beyond the limits of the physical map of the mutations, it follows that the mutations must lie within the structural gene for VP175. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis showed that most members of the group overproduced the immediate early proteins VP175, -136, -110, and -63 and markedly underproduced early and late proteins at the nonpermissive temperature. In temperature shiftup experiments, it was found that the synthesis of early and late proteins ceased, whereas the synthesis of immediate early proteins began again. Thus, it is postulated that VP175 is (i) involved in the transition from immediate early to early protein synthesis, (ii) required continuously to maintain early protein synthesis, and (iii) autoregulated, acting to inhibit immediate early protein synthesis.
The genome of herpes simplex virus type 1 (HSV-1) is large (molecular weight, 96 x 106) and structurally complex (1, 10, 11, 18, 38, 44) . Despite rapid progress in the genetic analysis of HSV, little is known about the regulation ofviral gene expression. The observation that the synthesis of three classes of viral polypeptides is sequentially and coordinately regulated was followed by the demonisration that coordinate regulation is at least partly controlled at the level of transcription (7, 8, 13, 14, 17, 22, 24, 25, 32, 43, 47) . More recently,.a viral gene has been identified which acts very early in the HSV replicative cycle and controls the transition from immediate early to early and late protein synthesis (8, 24, 25, 32) . This gene is located in the terminal repeats of S (20, 29, 33, 42) and is thought to encode a viral polypeptide of molecular weight 175,000, designated ICP4 (13) or VP175 (8) . A number of temperature-sensitive (ts) mutants in this gene have been isolated (5, 28, 36) . Studies with these mutants have revealed that VP175 controls a transcriptional event(s) which is essential for the transition from immediate early functions to early and late functions (28, 32, 47) .
Additionally, the gene is diploid (20, 27, 33) , presenting an unique situation for genetic analysis.
It is currently believed that VP175 is the product of gene 1-2; however, most of the evidence to support this contention is circumstantial. Thus, mutants defective in this gene overproduce VP175, the mutant protein exhibits altered intracellular compartmentalization and migration in sodium dodecyl sulfate (SDS)-gels, and the template specifying VP175 maps in the same region of the genome as do mutants in group 1-2 (27, 29, 41, 42) . To determine whether the lesions in mutants in group 1-2 are in the coding sequence for VP175, we have mapped nine ts mutants in group 1-2 by physical and genetic methods and correlated their order and map locations with the known location of DNA sequences which specify VP175 (27, 33) and the mRNA which encodes this protein (48) .
Other investigators have demonstrated that one function of the product of gene 1-2 involves transcriptional regulation (32, 47) . To further define the role of this protein in regulation, we have examined viral polypeptide synthesis by one mutant in the group, tsB21u, in temperature shiftup experiments. Our results demonstrate that VP175 is involved in mediating the transition from immediate early to early protein synthesis, that it is required continuously for the synthesis of some early and late proteins, and that it acts to inhibit its own synthesis.
MATERLALS AND MErHODS
Cells and cell culture. Serially propagated human embryonic lung fibroblasts (HEL), primary rabbit kidney cells (RK), and African green monkey kidney cells (Vero) were used. Cells were grown in Eagle minimal essential medium (Autopow; Flow Laboratories, Rockvile, Md.) containing 10% fetal bovine serum, 0.03% glutamine, and 0.025% NaHCO3. Cells were maintained in the same medium containing 5% fetal bovine serum. Virus stocks were grown, and complementation and recombination tests were performed in HEL cells; RK cells were used for the isolation of viral DNA and for marker rescue studies. Virus infectivity assays were performed in Vero cells.
Viruses and virus assays. The KOS strain of HSV-1 was used as the wild-type virus (40) . The isolation of mutants tsB2b, tsB21u, tsB27h, tsB28h, tsB32h, tsJ12g, ts90l, tsLB2, tsD, and tsc75 has been reported previously (4, 5, 12, 15, 20, 34) . The last four mutants were obtained from M. Levine, I. Halliburton, J. Subak-Sharpe, and R. Honess, respectively. Virus stocks were prepared and infectivities were determined as previously described (36) . In all tests, the permissive temperature was 34°C and the nonpermissive temperature was 390C.
Complementation tests and mapping procedures. Mutants tsB2b, ts9Ol, tMD, and tsLB2 were shown in a previous study to define complementation group 1-2 (36) . Complementation analysis with the other mutants used in this study is described herein. Complementation tests and recombination tests using two-factor crosses were carried out as described previously (34, 37 (31) were induced in infected cultures treated with 50 ug of cycloheximide (Calbiochem, La Jolla, Calif.) per ml from 0 to 7 h postinfection. The drug was removed after 7 h, monolayers were washed five times with Tris-saline, and medium containing 5 uCi of '4C-amino acids and 15 pg of actinomycin D (Calbiochem) per ml was added. Cells were harvested at 8 h postinfection by scraping into the medium. They were washed three times in Tris-buffered sline and suspended in water, and the resulting suspensions were frozen. Samples were later thawed, sonicated for 2 min, adjusted to 0.05 M Tris-hydrochloride (pH 6.7)-1% SDS-1% 2-mercaptoethanol-0.5 M urea, and boiled for 2 min. Electrophoresis was carried out on 7 to 15% linear gradient SDS-polyacrylamide slab gels (23) . The gels were fixed in 7% acetic acid and 50% methanol, impregnated with Enhance (New England Nuclear Corp., Boston, Mass.), and dried. The dried gels were then fluorographed at -70°C on Kodak SB-5 film.
RESULTS
Complementation studies with ts mutants. In two separate tests, eight of the nine ts mutants used in this study were shown to belong to complementation group 1-2 (5, 36). To confirn the assignment of these mutants and of tsc75 (20) to group 1-2, a quantitative yield-ofprogeny complementation test was performed (Table 1) ; tsJl2g, a member of group 1-9, was used as the positive control (36) . None of the nine mutants tested complemented each other, whereas all complemented tsJ12g (Table 1) . Thus, all nine mutants belonged to group 1-2. It should be noted that the nine mutants included in this study behave as if they possess point mutations in a single gene; i.e., they revert with low to moderate frequency (data not shown) and exhibit nonoverlapping patterns of complementation in tests with members of other groups (5, 36) .
Physical mapping experiments. Marker rescue studies were undertaken to determine the physical map locations of the nine ts mutants. We have reported previously that tsB21u lies within the "c" sequences in the terminal repeats of the S region of the genome (29) . This location is in agreement with the findings of Stow and Wilkie (42) and Knipe et al. (20, 21) , who placed tsLB2, tsD, and tsc75 within EcoRI fragment K, which contains S-terminal sequences "c" and Sta."Ps Table 2 shows the results of marker rescue experiments using purified EcoRI fragments shown in Fig. 1 . tsLB2, tsD, and tsc75 had been shown previously to be in fragment K (20, 21, 42) . Efficient rescue with the remaining six mutants was observed with fragment K (0.966 to 1.000) and with a mixture of fragments A, B, and C; fragments B and C are joint-spanning fragments, both of which contain sequences in K.
The EcoRI K fragment lies entirely within the terminally repeated sequences of the S region. Although we have not determined whether each mutation is present within both repeats, it is likely that this is the case, since fragments representing both ends of S have been shown to rescue tsB21u and the presence of the lesion in only one end would permit self-rescue of the mutant (29) . Moreover, like tsB21u, the terminal fragments of the L region (J and E) failed to rescue, indicating that none of the mutations lies within "a" sequences present at the joint and at the termini of the molecule. Rather, the mutations lie within the "c" sequences adjacent to Us (20, 29 (Fig. 1 ). When these fragments were used in marker rescue tests, the results shown in Table 3 Fig. 2 . In this figure, the limits of fragments which exhibited rescue are shown as bars. The white portion of each bar indicates sequences in which mutations are thought not to lie by the process of elimination; e.g., failure of the termini of L to rescue tsB32h, tsB28h, tsB27h, tsB2b, and tsB21u excludes their lying in the "a" sequences, whereas rescue of tsc75 by all four terminal fragments excludes its lying in the "c" sequences. Because direct tests of the sequences excluded by the process of elimination have not been conducted, the outermost limits of each bar should be considered definitive. The location of tsD (0.966 to 0.900) was taken from Stow et al. (41, 42) . It should be mentioned that Wilkie and his colleagues have recently refined the limits of tsD and of tsK, another member of group 1-2, to coordinates, 0.979 to 0.990 and 0.966 to 0.978, respectively (personal communication). The sequence of mutations on the physical map is therefore tsK-tsLB2, tsD-ts901, tsB32h-tsB28h-tsB27h-tsB2b-tsB21u, and tsc75.
The location of the sequence specifying VP175 as deternined by heterotypic recombination and marker rescue (27, 33) and the 4.7-kb mRNA which codes for VP175 (48) are also shown in (27) Fig. 2 ). The following observations concerning the linkage map are notable. First, the mutants clustered into four groups, each separated by 1.4 to 1.9 recombination units. The first group contained mutants tsB2b, tsB21u, and tsB27h; the second contained mutants tsB28h, tsB32h, and tsLB2; the third contained tsD; and the fourth contained ts9Ol. Second, although the mutants clustered into groups, no mutational hot-spotting was evident (i.e., all mutations induced with one mutagen were not located in one place). Both thymidine-specific (bromodeoxyuridine and VOL. 36, 1980 UV) and cytosine-specific (hydroxylamine) mutagens were used for mutant induction, and mutations derived with either type of mutagen were randomly arranged on the map. Third, although the physical map is not sufficiently detailed to establish the order of mutants within each of the groups, the genetic and physical maps are colinear with respect to the order of seven of the nine mutants tested: tsD-ts901 and tsB32h-tsB28h-tsB27h-tsB2b-tsB21u. Only tsLB2 is out of order on the genetic map. Fourth, the recom- (20) (Table 4) . More-property, cells were infected with each mutant, over, tsc75 appears to be closely linked to tMD, incubated at 39°C, and labeled from 5 to 24 h yet it is located in the "a" sequences at the end postinfection. All of the mutants exhibited a of the physical map. It may be that mutant tsc75 similar but not identical polypeptide phenotype contains multiple mutations, the possible origins at 390C (Fig. 3) . Thus, for all mutants, immediof which will be discussed later.
ate early polypeptides VP175, -68, and -63 were Polypeptide synthesis in ts mutant-in-overproduced. These Figure 3 also includes the various molecular weights and nomenclatures used in the literature to describe these polypeptides. In this report, we have used the nomenclature of Preston (31) (Fig. 3, column  B) .
Temperature shift experiments. To determine whether functional VP175 is required only transiently or throughout the replicative cycle, temperature shiftup experiments were performed with tsB21u. In the first experiment, tsB21u-infected cells were incubated for various lengths of time at 34°C before shiftup to 390C; all cultures were labeled at the time of shift and harvested at 24 h (Fig. 4) .
When cultures were incubated continuously at 390C (Fig. 4, lane b) , overproduction of immediate early polypeptides VP175, -136, -110, and -63 was evident. Late polypeptides VP154 and VP100 and early polypeptide VP64 were minor species in these cells. In contrast, early and late polypeptides predominated in cultures incubated at 340C from 1, 2, 4, or 8 through 24
h (Fig. 4, lanes c, e, g, and i ).
In cultures shifted up at 1, 2, and 4 h (Fig. 4,  lanes d, f, and h (30) . Thus, the protein seen at later times may be the immediate early polypeptide, VP110, the early polypeptide, or both. Clearly, however, the synthesis of VP175, -136, and -VP63 was not shut off after shiftup even though many early and late proteins were being synthesized simultaneously. Thus, despite the current hypothesis that early viral proteins are required to turn off immediate early protein synthesis, these proteins continued to be synthesized in the presence of early proteins. Because the only essential lesion in tsB21u is in the gene for VP175, these observations suggest the possibility that VP175 is involved in the inhibition of immediate early protein synthesis or, alternatively, that VP175 is required continuously to produce a factor required to shut off the synthesis of this class of polypeptides. Even when the shift occurred as late as 8 h (Fig. 4, lane j) , the expression of VP175 was still greater than in the 340C control (lane i). Additional differences were noted when proteins were synthesized after shift to 390C
An additional observation made from this gel concerns variation in the electrophoretic mobility of VP175. In all cases, the VP175 polypeptide made at 340C migrated more slowly than that made at 390C (most clearly seen in lanes e, f, g, and h of Functional VP175 has been shown to be required only transiently for viral DNA synthesis, the requirement being bypassed by a 2-h preincubation at 340C (35) . The results of the present study demonstrate that continued synthesis of VP175 is required for the expression of certain late viral gene products (see above). The requirement for functional VP175 in the synthesis of infectious virus, however, has not been examined. Therefore, the yield of infectious virus in cultures infected as for shiftup tests (Fig. 4) was measured (Table 5) .
In unshifted cultures, tsB21u was temperature sensitive for growth when compared with the wild-type virus, as expected. When mutant-infected cultures were shifted up at 1, 2, 4, and 8 h and yields were assayed after 24 h, they were only 10-fold higher than the yield from the culture incubated at 390C. Thus, unlike viral DNA synthesis, functional VP175 is apparently required after 8 VP175 synthesized after shiftup at 8 h (Fig. 4 , lane j), it is possible that the same sequences which specify VP175 also specify a later function required for infectivity, and that a mutation in the sequences specifying VP175 could also inactivate this putative later function.
The experiment illustrated in Fig. 4 demonstrated that VP175 synthesis was not shut off (Fig. 5) , such synthesis was not observed in other experiments. The relative stability of the protein at the two temperatures was identical, however.
Additional evidence for the reexpression of immediate early polypeptides after shiftup comes from the observation that when tsB21u-infected cells were shifted at 4 or 8 h and either pulse-labeled immediately for 1 h or pulse-labeled 2 h after the shiftup, the same level of synthesis of VP175 was observed (data not shown). Because the half-life of the early mRNA's is only 1 h (46), it would be necessary to synthesize new mRNA in order to maintain the same rate of protein synthesis. In this experiment, expression of VP175 in cultures shifted up at 8 h was observed, whereas no expression of VP175 was observed in cultures labeled at 340C during the same period, again indicating that VP175 is reexpressed and therefore involved in inhibiting its own synthesis.
An additional observation made from the gels shown in Fig. 5 concerns the active form of VP175. It is apparent from Fig. 4 and 5 that the form of VP175 which accumulated at 340C was of higher apparent molecular weight than the form which accumulated at 390C. After pulselabeling, a fast-migrating form was synthesized, and this form could be chased to a slower-migrating form which accumulated at 390C (Fig. 5 , lanes m and n). After shift from 39 to 340C and chase (lane o), a slight change in apparent molecular weight was evident. As mentioned above, the finding of three electrophoretic variants of VP175 is consistent with the reports of Pereira et al. (30) , Preston (31) , and Wilcox et al. (49), who have described three forms of the protein (VP175a, -b, and -c or ICP4a, -b, and -c) which share a precursor-product relationship. Preston noted that upon shift from 34 to 390C, VP175c was converted to VP175b, with loss of activity (31) . Consistent with this observation, we found that VP175b was converted to VP175c upon shiftdown. Of additional interest is Preston's finding that upon shiftdown in the presence of cycloheximide, no new protein synthesis was required for early transcription (32) . From these observations, it appears that the "c" forn is the active form of VP175. Although the nature of the modification in VP175 is not known, Wilcox et al. (49) have presented evidence which implicates phosphorylation in the modification process. Whatever the mechanism of modification, it is essential for functional activity. tion and function of the gene encoding VP175. The original description of cascade regulation in the HSV-1 replicative cycle (13) led to the identification of a group of proteins (immediate early, or a, proteins) which are synthesized immediately after infection and whose synthesis is required for the initiation of synthesis of a second group of proteins, the early, or ,B, proteins.
Early proteins were shown to play a role in the shutoff of immediate early protein synthesis (13, 14) .
Among the immediate early proteins first de-scribed were VP175, -110, and -63 (13) . The existence of a mutant, tsB2b, which overproduced VP175 and was defective in the transition from immediate early to late protein synthesis was reported simultaneously (8) . The latter study also demonstrated that in tsB2b-infected cells, VP175 was not transported to the nucleus as efficiently as in wild-type virus-infected cells at the nonpermissive temperature. Both the transition from immediate early to late protein synthesis and transport to the nucleus could be reversed upon shiftdown and bypassed by preincubation at the permissive temperature, indicating that the defective function in this mutant was both early and reversible. Subsequent experiments demonstrated that functional VP175 was essential for viral DNA synthesis and that the requirement could be bypassed by preincubation for 2 h at the permissive temperature (35) . More recently, it was shown that upon shiftdown, new transcription was required for viral DNA synthesis in cells infected with tsB2b (28) . Other investigators have isolated additional ts mutants of complementation group 1-2 (D, T, K, and LB2) (36) which possess similar phenotypic properties. Preston (32) has reported that at least six immediate early polypeptides (VP175, -136, -110, -68, -63, and -12) are synthesized in vivo after release of a cycloheximide block and that in vitro translation of immediate early mRNA yields these same products. Preston has also compared the synthesis of immediate early polypeptides in tsK and wild-type virus-infected cells and has obtained evidence which demonstrates that (i) immediate early proteins are directly involved in the transition from immediate early to early protein synthesis, (ii) three forms of VP175 exist, and (iii) upon temperature shiftdown, the multiple effects of the mutations are reversible. In contrast, Pereira et al. (30) placed VP136 in the group of early proteins despite the fact that it is synthesized in the presence of cycloheximide or canavanine.
This classification was based upon the observation that VP136 was synthesized slightly later than the other immediate early proteins.
To confirm that the product of gene 1-2 is indeed VP175 and to further define the function ofthis protein in the regulation ofviral transcription, studies were undertaken to map physically and genetically a series of mutants in group [1] [2] and to characterize the residual activity of mutant gene products in infected cells at the nonpermissive temperature.
Mapping studies. Previously, studies have shown that tsB21u (29) , tsB2b (3), tsD (41, 42) , tsLB2 (21) , and tsc75 (22) lie in the repeated sequences bounding Us. In this study, we have attempted to refine the map positions of several mutants in complementation group 1-2 and to separate them physically within these sequences.
It is our contention that the data presented here together with the findings of other investigators place the mutants within the structural gene for VP175. The pertinent arguments for this contention are as follows: the nine mutants (i) fail to complement each other, (ii) exhibit similar viral DNA and protein phenotypes, (iii) produce an altered form of VP175, (iv) are separable by physical and genetic mapping procedures, and (v) map within the DNA sequences which encode VP175. Moreover, VP175 is the only protein which has been shown to be encoded within these sequences, and (vi) a 4.7-kb immediate early mRNA coding for a protein of molecular weight 175,000 also maps in these sequences (6) . Therefore, unless extensive splicing occurs in production of the message for VP175, and no evidence for such splicing has yet been reported, the nine mutants must lie in the structural gene for VP175. Mapping studies therefore exclude the possibility that the phenotypic properties of mutants of group 1-2 are due to mutations in a gene which regulates VP175 synthesis.
As described above (Results), most mutants map nearer the terminal "a" sequences than the unique region of S. Two possible explanations for this observation exist: (i) this segment of the VP175 gene, if mutated, results in significant, observable phenotypic changes (e.g., this segment encodes an active site), or (ii) some property of the DNA makes it highly mutable. We cannot test the forner possibility at this time; however, the latter lends itself to speculation. Knipe et al. (21) have demonstrated regions of identity between the terminal "ca" sequences in S and have proposed a copying mechanism whereby, during DNA replication, one terminus serves as the template for the other. They further postulated that "c" sequences further from the terminal "a" sequences can tolerate sequence heterogeneity more readily than the "c" sequences nearer "a." Thus, the former sequences have been designated variable "c" sequences, and those nearer terminal "a" sequences have been designated invariable "c" sequences. These investigators also demonstrated that ts lesions in VP175 are recessive.
Thus, sequences at only one terminus need be wild type to generate the wild-type phenotype, whereas sequences at both termini must be mutant to generate the ts phenotype (21, 31, 33) . Our data are consistent with this hypothesis in that a mutation induced in invariable "c" sequences would be more likely to be copied into the opposite terminus, yielding a mutant phe-VOL. 36, 1980 on November 6, 2017 by guest http://jvi.asm.org/ notype, than would a mutation in variable "c" sequences, which could produce a "silent" mutant phenotype. Thus, perhaps, the copying mechanism of DNA synthesis constitutes the underlying reason for the isolation of a predominance of ts mutations in invariable, terminal "c" sequences. Further analysis of the remaining members of group 1-2 and efforts to introduce mutations into the variable and invariable sequences in one terminus but not the other will be necessary to prove this hypothesis.
The genetic map of the nine mutants exhibits striking linearity and additivity, much more so than linkage maps of markers in unique sequences in L (37; Dixon and Schaffer, manuscript in preparation). Moreover, the recombination frequencies observed among mutants in group 1-2 were much higher than those observed between markers within a single gene in the unique region (Dixon and Schaffer, manuscript in preparation). The diploid nature of the gene may account for the high frequency of recombination since only one terminus need recombine to yield a ts+ recombinant: crossovers at either end would produce twice the effective recombination frequency.
Another interesting observation which arose from recombination studies concerns the behavior of tsc75. This mutant recombines inefficiently with other members of group 1-2. In addition, it behaves as if it were closely linked to tsD, yet it has been mapped physically in the terminal "a" sequences (20) . A possible explanation for these findings is that the "a" sequence may, in fact, be repeated within "c" sequences. This suggestion was first made by Wadsworth et al. (44) , who demonstrated small lariat structures at the ends of molecules which had been digested with exonuclease III, and proposed that the sequence arrangement of the S region may be .. .a'x'a c'---Us---ca'xa. We will assume for the sake of argument that this arrangement is correct. If the "a" sequence is diploid in each repeat and if tsc75 does lie within the "a" sequence, at least two copies of the mutant "a" sequence would be present in order to prevent self-rescue. Although Knipe et al. (20) have proposed that the coding sequences for VP175 include the terminal "a" sequence, this need not be the case. In fact, it may be a mutation in the internal "a" sequence which produces the mutant phenotype, or perhaps mutations in both "a" sequences. Our genetic and physical mapping data support this contention. If the mutation in the internal "a" sequence were essential for the expression of the ts phenotype, and if this sequence were adjacent to tsD, then the position of tsc75 found by recombination analysis would be predicted. Moreover, if "a" sequences were also present in "c" sequences, one would predict that tsc75 would be rescued by fragment K2 (containing the terminal "a" sequence) and by fragment K3 (containing the putative "a" sequence in "c"). Indeed, this is precisely the result we obtained.
Alternatively, the low frequency of recombination observed between tsc75 and other members of group 1-2 may reflect the fact that recombination occurs with decreased frequency at the ends of molecules. Thus, low recombination frequencies with markers in the terminal "a" sequence could result in mismapping. This explanation is inconsistent, however, with rescue of tsc75 by both K2 and K3.
Function of VP175. Having demonstrated that all nine mutants in complementation group 1-2 are located in the structural gene for VP175, further functional analysis of this polypeptide was undertaken.
We first demonstrated that all nine mutants exhibit similar phenotypes with regard to polypeptide synthesis at the nonpermissive temperature. Minor variations in the amounts of certain polypeptides were observed, owing perhaps to strain variation or leak, but in most cases VP175, -136, -110, -68, and -63 were seen to be overproduced. In tsc75-infected cells, however, increased amounts of VP110 accumulated relative to the other mutants. Although this may simply reflect a strain-specific difference, it may also reflect some unusual properties of VP110. Clements et al. (6) and Watson et al. (48) have shown that VP110 is encoded by the terminal repeats of the L region. Because the "a" sequence is common to the repeats of both L and S and because the mRNA coding for VP110 may contain a terminal "a" sequence, it is possible that tsc75 is mutant for both VP175 and VP110 and is, therefore, a nonresolvable double mutant. If tsc75 contains a mutation in the gene for VP110, then the accumulation of VP110 in mutant-infected cells may reflect a role for VP110 in its own regulation or, alternatively, it may reflect a failure to process the mutant form of VP110 analogous to mutants in VP175. Because no single mutant in VP110 is available, we cannot distinguish between the two possibilities.
Several groups have reported that functional VP175 is required to switch from immediate early to early protein synthesis and that the requirement is probably at the level of transcription (7, 8, 13, 14, 22, 24, 25, 32, 43, 47) . What is not clear is the role of early proteins in regulating immediate early protein synthesis and the role of VP175 in regulating its own synthesis. Temperature shiftup experiments have shown that VP175 as well as other immediate early proteins can be synthesized in the presence of both early and late functional proteins, indicating that VP175 is involved either directly or indirectly in turning off its own synthesis and perhaps that of other immediate early proteins. This conclusion was particularly apparent in the case of shifts late in infection which resulted in the reexpression or increased synthesis of immediate early proteins (Fig. 4) . If this is indeed the case, then the model of cascade regulation must be modified to include autoregulation of immediate early proteins in addition to feedback inhibition by early proteins.
Another point to be made concerns the existence of multiple control groups in each polypeptide class. Pereira et al. (30) first suggested that subgroups of immediate early and early proteins existed, a concept supported by Preston (32) . Our experiments have defined a group of proteins which are active late in infection (after 8 h) and yet require the continued expression of VP175. This is apparent from the differences seen in polypeptide synthesis after shiftup late in infection and from the observation that no virus was produced even though most proteins were synthesized (35 (19, 24, 25) , (iv) functional VP175 is able to enhance HSV TK expression in HSV TK-transformed cells (19, 24, 25) , (v) VP175 is reexpressed in group 1-2 mutant-infected cells after shiftup (i.e., after inactivation of the autoregulatory function of VP175) (this study), and (vi) the active form of VP175 has DNA binding properties (49). If this model were correct, one might expect VP175 to bind directly to promoter sequences or perhaps to form complexes with the RNA polymerase to alter its specificity. This transcriptional model is similar in many ways to the regulatory mechanism operative during adenovirus replication in which pre-early proteins are required to initiate the synthesis of early proteins, which in turn initiate later protein synthesis (2, 16) . However, during transcription in vitro, the major late promoter(s) is recognized in preference to the early promoter(s) (J. Manley, personal communication). This indicates that although early functions are needed to enhance late promoter activity, they can be bypassed by the cellular transcriptional complex.
